These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

311 related items for PubMed ID: 19065749

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Emerging therapies in juvenile rheumatoid/idiopathic arthritis.
    Passo M.
    Curr Probl Pediatr Adolesc Health Care; 2006 Mar; 36(3):97-103. PubMed ID: 16473286
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. New drugs for rheumatoid arthritis.
    Messori A, Santarlasci B, Vaiani M.
    N Engl J Med; 2004 Aug 26; 351(9):937-8. PubMed ID: 15329436
    [No Abstract] [Full Text] [Related]

  • 6. Adalimumab with or without methotrexate in juvenile rheumatoid arthritis.
    Lovell DJ, Ruperto N, Goodman S, Reiff A, Jung L, Jarosova K, Nemcova D, Mouy R, Sandborg C, Bohnsack J, Elewaut D, Foeldvari I, Gerloni V, Rovensky J, Minden K, Vehe RK, Weiner LW, Horneff G, Huppertz HI, Olson NY, Medich JR, Carcereri-De-Prati R, McIlraith MJ, Giannini EH, Martini A, Pediatric Rheumatology Collaborative Study Group, Pediatric Rheumatology International Trials Organisation.
    N Engl J Med; 2008 Aug 21; 359(8):810-20. PubMed ID: 18716298
    [Abstract] [Full Text] [Related]

  • 7. Adalimumab in juvenile rheumatoid arthritis.
    Sfriso P, Ravaioli F.
    N Engl J Med; 2008 Dec 04; 359(23):2495; author reply 2496-7. PubMed ID: 19052133
    [No Abstract] [Full Text] [Related]

  • 8. Tumor necrosis factor-blocking agents for children with enthesitis-related arthritis--data from the dutch arthritis and biologicals in children register, 1999-2010.
    Otten MH, Prince FH, Twilt M, Ten Cate R, Armbrust W, Hoppenreijs EP, Koopman-Keemink Y, Wulffraat NM, Gorter SL, Dolman KM, Swart JF, van den Berg JM, van Rossum MA, van Suijlekom-Smit LW.
    J Rheumatol; 2011 Oct 04; 38(10):2258-63. PubMed ID: 21844151
    [Abstract] [Full Text] [Related]

  • 9. Occurrence of inflammatory bowel disease in four patients with juvenile idiopathic arthritis receiving etanercept or infliximab.
    Tarkiainen M, Tynjälä P, Vähäsalo P, Lahdenne P.
    Scand J Rheumatol; 2011 Mar 04; 40(2):150-2. PubMed ID: 20868307
    [No Abstract] [Full Text] [Related]

  • 10. Clinical remission in patients with systemic juvenile idiopathic arthritis treated with anti-tumor necrosis factor agents.
    Russo RA, Katsicas MM.
    J Rheumatol; 2009 May 04; 36(5):1078-82. PubMed ID: 19435972
    [Abstract] [Full Text] [Related]

  • 11. New treatments for juvenile idiopathic arthritis.
    Hashkes PJ, Friedland O, Uziel Y.
    Isr Med Assoc J; 2002 Jan 04; 4(1):39-43. PubMed ID: 11802310
    [No Abstract] [Full Text] [Related]

  • 12. Update on the British Society for Rheumatology guidelines for prescribing TNFalpha blockers in adults with rheumatoid arthritis (update of previous guidelines of April 2001).
    Ledingham J, Deighton C, British Society for Rheumatology Standards, Guidelines and Audit Working Group.
    Rheumatology (Oxford); 2005 Feb 04; 44(2):157-63. PubMed ID: 15637039
    [No Abstract] [Full Text] [Related]

  • 13. Secondary syphilis following tumor necrosis factor-α inhibitor treatment for rheumatoid arthritis.
    Asahina A, Ishii N, Tohma S.
    J Dermatol; 2012 Feb 04; 39(2):199-201. PubMed ID: 21463364
    [No Abstract] [Full Text] [Related]

  • 14. Tumor necrosis factor inhibitors for rheumatoid arthritis.
    Scott DL, Kingsley GH.
    N Engl J Med; 2006 Aug 17; 355(7):704-12. PubMed ID: 16914706
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Sarcoidosis during anti-tumor necrosis factor-alpha therapy: no relapse after rechallenge.
    van der Stoep D, Braunstahl GJ, van Zeben J, Wouters J.
    J Rheumatol; 2009 Dec 17; 36(12):2847-8. PubMed ID: 19966199
    [No Abstract] [Full Text] [Related]

  • 18. Drug survival of the first and second course of anti-tumour necrosis factor agents in juvenile idiopathic arthritis.
    Tynjälä P, Vähäsalo P, Honkanen V, Lahdenne P.
    Ann Rheum Dis; 2009 Apr 17; 68(4):552-7. PubMed ID: 18467515
    [Abstract] [Full Text] [Related]

  • 19. Anti-TNF-alpha therapies: they are all the same (aren't they?).
    Mpofu S, Fatima F, Moots RJ.
    Rheumatology (Oxford); 2005 Mar 17; 44(3):271-3. PubMed ID: 15561736
    [No Abstract] [Full Text] [Related]

  • 20. Adalimumab in juvenile rheumatoid arthritis.
    de Vries MK, van der Horst-Bruinsma IE, Wolbink GJ.
    N Engl J Med; 2008 Dec 04; 359(23):2496; author reply 2496-7. PubMed ID: 19065700
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.